An exploratory study of venetoclax in combination with bortezomib-cyclophosphamide-dexamethasone (VCD) induction therapy in newly diagnosed transplant eligible (NDTE MM) multiple myeloma with proteomic correlative studies.
- Spencer, Andrew (Primary Chief Investigator (PCI))
- Kennedy, Nola (Project Manager)
- Mollee, Peter (Chief Investigator (CI))
- Harrison, Simon James (Chief Investigator (CI))
- Quach, Hang, (Chief Investigator (CI))
- Ho, Joy (Chief Investigator (CI))
Project: Research